The FCT project entitled “Ruthenium-peptide conjugates: arrows for selectively targeting breast cancer” (Arrows2cancer) aims to contribute to the chemotherapy field through the development of innovative drugs for triple negative breast cancer. In particular, it aims at overcoming the limitations of the current drugs by developing smart drug delivery systems of ruthenium selectively to primary tumors and metastases of triple negative breast cancer.
Coordinator of the project (PI): João D. G. Correia – jgalamba@ctn.tecnico.ulisboa.pt